Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Anuh Pharma Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹77.56
High
₹79.75
Price Summary
| Previous Close | ₹79.07 |
|---|---|
| Day's Range | ₹77.56 - ₹79.75 |
| Open | ₹77.56 |
| 52 Week Range | ₹67.00 - ₹100.00 |
| Volume | 17,342 |
| Market Cap | ₹0.00 |
| Previous Close | ₹79.13 |
|---|---|
| Day's Range | ₹78.91 - ₹79.98 |
| Open | ₹79.98 |
| 52 Week Range | ₹66.72 - ₹103.80 |
| Volume | 1,952 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 13.67 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 1.90 |
| Price/Earning (TTM) | 19.32 |
| TTM EPS (₹) | 4.10 |
| P/E Ratio | 16.39 |
| Book Value(₹) | 2.25 |
| PAT Margin (%) | 5.27 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 16.02 |
| Trade Value ( ₹ in Lacs) | 1.55 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 1.90 |
| Price/Earning (TTM) | 19.32 |
| TTM EPS (₹) | 4.10 |
| P/E Ratio | 16.39 |
| Book Value(₹) | 2.25 |
| PAT Margin (%) | 5.27 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 16.02 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 6615.15 | 1981.4 |
| Expenses | N/A | N/A |
| PBT | 610.05 | 172.8 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 473.52 | 124.57 |
About Anuh Pharma Ltd.
| Founded | 1960 |
|---|---|
| NSE Symbol | ANUHPHR |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,65,710.92 | 1,941.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,92,375.79 | 7,240.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,654.85 | 4,959.80 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,26,592.33 | 8,816.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,978.90 | 1,409.95 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,10,613.20 | 1,108.90 | 835.50 - 835.50 |
| Lupin Ltd. | 1,08,339.52 | 2,374.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,05,259.52 | 1,078.90 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,03,472.01 | 2,509.65 | 1,909.70 - 1,909.70 |
| Lenskart Solutions Ltd. | 96,638.09 | 557.45 | 0.00 - 0.00 |
No Records Found
Latest News
May
22
2026
Posted on May 22nd 2026
Anuh Pharma informs about newspaper publication
Anuh Pharma has informed that pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, advertisement have been published by the company on Friday, 22nd May, 2026 in Financial Express (English) and Mumbai Lakshdeep (Marathi) Edition pertaining to Audited Financial Results containing a Quick Response Code and the details of the Webpage where the aforesaid complete Financial Results of the Company for the quarter and year ended 31st March, 2026 is accessible. Copies of said publications are enclosed for information and record. This disclosure is being simultaneously uploaded on the website of the company, www.anuhpharma.com
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
28
2026
Posted on Apr 28th 2026
Anuh Pharma informs about press release
Anuh Pharma has informed that the Company has published advertisements in the newspapers Financial Express (English) and Mumbai Lakshdeep (Marathi) editions on Tuesday, 28th April, 2026. This advertisement informs shareholders of Anuh Pharma (‘the Company’) that relate to the initiation of a second phase of 100-day campaign by the Company titled ‘Saksham Niveshak by the Investor Education and Protection Fund Authority (‘IEPFA’), Ministry of Corporate Affairs. Copies of the published advertisements are enclosed herewith. This disclosure is being simultaneously uploaded on the Company’s website: www.anuhpharma.com
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
25
2026
Posted on Jul 25th 2026
Laurus Labs - Quaterly Results
The company witnessed a 22.64% growth in the revenue at Rs. 17571.60 millions for the quarter ended June 2026 as compared to Rs. 14327.50 millions during the year-ago period.Profit for the quarter ended June 2026 rises by 83.59% to Rs. 2899.60 millions from Rs. 1579.40 millions.Operating profit for the quarter ended June 2026 rose to 5191.30 millions as compared to 3489.00 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 17571.60 | 14327.50 | 22.64 | 17571.60 | 14327.50 | 22.64 | 60890.70 | 52169.80 | 16.72 |
| Other Income | 200.70 | 215.20 | -6.74 | 200.70 | 215.20 | -6.74 | 774.30 | 1004.70 | -22.93 |
| PBIDT | 5191.30 | 3489.00 | 48.79 | 5191.30 | 3489.00 | 48.79 | 15156.90 | 10448.00 | 45.07 |
| Interest | 352.00 | 438.90 | -19.80 | 352.00 | 438.90 | -19.80 | 1429.60 | 1822.00 | -21.54 |
| PBDT | 4839.30 | 3050.10 | 58.66 | 4839.30 | 3050.10 | 58.66 | 13727.30 | 8626.00 | 59.14 |
| Depreciation | 957.60 | 935.70 | 2.34 | 957.60 | 935.70 | 2.34 | 3786.40 | 3587.90 | 5.53 |
| PBT | 3881.70 | 2114.40 | 83.58 | 3881.70 | 2114.40 | 83.58 | 9940.90 | 5038.10 | 97.31 |
| TAX | 982.10 | 535.00 | 83.57 | 982.10 | 535.00 | 83.57 | 2536.10 | 1234.20 | 105.49 |
| Deferred Tax | -50.40 | -61.60 | -18.18 | -50.40 | -61.60 | -18.18 | -315.10 | -304.20 | 3.58 |
| PAT | 2899.60 | 1579.40 | 83.59 | 2899.60 | 1579.40 | 83.59 | 7404.80 | 3803.90 | 94.66 |
| Equity | 1080.50 | 1079.60 | 0.08 | 1080.50 | 1079.60 | 0.08 | 1079.70 | 1078.50 | 0.11 |
| PBIDTM(%) | 29.54 | 24.35 | 21.32 | 29.54 | 24.35 | 21.32 | 24.89 | 20.03 | 24.29 |
Read More
Jul
25
2026
Posted on Jul 25th 2026
Onesource Specialty - Quaterly Results
A decent increase of about 39.08% in the sales to Rs. 4464.71 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 3210.12 millions during the year-ago period.The company almost doubled its revenue to Rs. 512.25 millions from Rs. 248.15 millions in the quarter ended June 2026.Operating Profit saw a handsome growth to 1179.19 millions from 851.30 millions in the quarter ended June 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 4464.71 | 3210.12 | 39.08 | 4464.71 | 3210.12 | 39.08 | 14053.81 | 12995.89 | 8.14 |
| Other Income | 37.87 | 52.55 | -27.94 | 37.87 | 52.55 | -27.94 | 150.08 | 176.82 | -15.12 |
| PBIDT | 1179.19 | 851.30 | 38.52 | 1179.19 | 851.30 | 38.52 | 2840.01 | 3869.57 | -26.61 |
| Interest | 305.17 | 270.31 | 12.90 | 305.17 | 270.31 | 12.90 | 1205.76 | 1616.50 | -25.41 |
| PBDT | 874.02 | 580.99 | 50.44 | 874.02 | 580.99 | 50.44 | 1580.05 | 1130.57 | 39.76 |
| Depreciation | 361.77 | 332.84 | 8.69 | 361.77 | 332.84 | 8.69 | 1367.95 | 1345.12 | 1.70 |
| PBT | 512.25 | 248.15 | 106.43 | 512.25 | 248.15 | 106.43 | 212.10 | -214.55 | -198.86 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -414.55 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -414.55 | 0.00 |
| PAT | 512.25 | 248.15 | 106.43 | 512.25 | 248.15 | 106.43 | 212.10 | 200.00 | 6.05 |
| Equity | 114.64 | 114.46 | 0.16 | 114.64 | 114.46 | 0.16 | 114.62 | 114.43 | 0.17 |
| PBIDTM(%) | 26.41 | 26.52 | -0.41 | 26.41 | 26.52 | -0.41 | 20.21 | 29.78 | -32.13 |
Read More
Jul
25
2026
Posted on Jul 25th 2026
Dr. Lal Pathlabs - Quaterly Results
The company witnessed a 19.31% growth in the revenue at Rs. 7644.00 millions for the quarter ended June 2026 as compared to Rs. 6407.00 millions during the year-ago period.The company has announced a 28.31% increase in its profits to Rs . 1659.00 millions for the quarter ended June 2026 compared to Rs. 1293.00 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 2684.00 millions from 2097.00 millions in the quarter ended June 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 7644.00 | 6407.00 | 19.31 | 7644.00 | 6407.00 | 19.31 | 26476.00 | 23516.00 | 12.59 |
| Other Income | 299.00 | 263.00 | 13.69 | 299.00 | 263.00 | 13.69 | 1127.00 | 1115.00 | 1.08 |
| PBIDT | 2684.00 | 2097.00 | 27.99 | 2684.00 | 2097.00 | 27.99 | 8664.00 | 7770.00 | 11.51 |
| Interest | 61.00 | 45.00 | 35.56 | 61.00 | 45.00 | 35.56 | 220.00 | 215.00 | 2.33 |
| PBDT | 2623.00 | 2052.00 | 27.83 | 2623.00 | 2052.00 | 27.83 | 8143.00 | 7555.00 | 7.78 |
| Depreciation | 400.00 | 328.00 | 21.95 | 400.00 | 328.00 | 21.95 | 1541.00 | 1342.00 | 14.83 |
| PBT | 2223.00 | 1724.00 | 28.94 | 2223.00 | 1724.00 | 28.94 | 6602.00 | 6213.00 | 6.26 |
| TAX | 564.00 | 431.00 | 30.86 | 564.00 | 431.00 | 30.86 | 1520.00 | 1240.00 | 22.58 |
| Deferred Tax | -9.00 | 22.00 | -140.91 | -9.00 | 22.00 | -140.91 | 14.00 | -393.00 | -103.56 |
| PAT | 1659.00 | 1293.00 | 28.31 | 1659.00 | 1293.00 | 28.31 | 5082.00 | 4973.00 | 2.19 |
| Equity | 1676.00 | 838.00 | 100.00 | 1676.00 | 838.00 | 100.00 | 1676.00 | 836.00 | 100.48 |
| PBIDTM(%) | 35.11 | 32.73 | 7.28 | 35.11 | 32.73 | 7.28 | 32.72 | 33.04 | -0.96 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Anuh Pharma Ltd. is ₹79.07 as of 2026-07-24.
The market capitalisation of Anuh Pharma Ltd. is ₹793.07 as of 2026-07-24.
The 1-year return of Anuh Pharma Ltd. is -21.06% as of 2026-07-24.
The P/E ratio of Anuh Pharma Ltd. is 16.39 as of 2026-07-25.
The 52-week high and low of Anuh Pharma Ltd. are ₹100.00 and ₹67.00, respectively, as of 2026-07-24.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
